Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    CAS 349535-15-5 manufacturers and suppliers on PharmaCompass

    Client Email Product

    CAS 349535-15-5

    Manufacturers/Suppliers

    PharmaCompass
    CAS 349535-15-5
    Also known as: 349535-15-5, 1-(1-methylpiperidin-4-yl)piperazine 3hcl, Cs-0145450, 1-(1-methylpiperidin-4-yl)piperazine;trihydrochloride
    Molecular Formula
    C10H24Cl3N3
    Molecular Weight
    292.7  g/mol
    InChI Key
    NDZOOUAUKYVQEO-UHFFFAOYSA-N
    1 2D Structure

    CAS 349535-15-5

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-(1-methylpiperidin-4-yl)piperazine;trihydrochloride
    2.1.2 InChI
    InChI=1S/C10H21N3.3ClH/c1-12-6-2-10(3-7-12)13-8-4-11-5-9-13;;;/h10-11H,2-9H2,1H3;3*1H
    2.1.3 InChI Key
    NDZOOUAUKYVQEO-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CN1CCC(CC1)N2CCNCC2.Cl.Cl.Cl
    2.2 Synonyms
    2.2.1 Depositor-Supplied Synonyms

    1. 349535-15-5

    2. 1-(1-methylpiperidin-4-yl)piperazine 3hcl

    3. Cs-0145450

    4. 1-(1-methylpiperidin-4-yl)piperazine;trihydrochloride

    2.3 Create Date
    2013-10-25
    3 Chemical and Physical Properties
    Molecular Weight 292.7 g/mol
    Molecular Formula C10H24Cl3N3
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count1
    Exact Mass g/mol
    Monoisotopic Mass g/mol
    Topological Polar Surface Area18.5
    Heavy Atom Count16
    Formal Charge0
    Complexity146
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count4
    ListList of Suppliers
    Full View ScreenFull Screen View
    refresh Reset Filter
    refresh Reset Filter
    price-trend Ask Us

    Porton Pharma Solutions

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zavegepant

    PDF Supplier PDF
    URL Supplier Web Content
    349535-15-5
    1-(1-methylpiperidin-4- yl)piperazi...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzh...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    fermion-oy-2024-05-13

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Inke S.A: APIs manufacturing plant.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search